Axol Bioscience is a startup based in the United Kingdom, most recent round Series-c-plus, 2 tracked investors.
Based in the United Kingdom, Axol Bioscience is a startup. Its most recent tracked round is Series-c-plus. Brouky records 2 investors associated with the company.
Axol Bioscience supplies human induced pluripotent stem cell (iPSC)-derived cells and custom laboratory services to model human diseases, focusing on neurodegenerative conditions like Alzheimer’s and Parkinson’s, as well as cardiovascular research.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.